About Florida Cancer Specialists & Research Institute, LLC: (Homepage)
Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida. The majority of new cancer drugs recently approved for use in the U.S. were studied in clinical trials with FCS participation.* Recognized for our research, FCS is a recipient of the national Clinical Trials Participation Award presented by the American Society of Clinical Oncology (ASCO). FCS physicians, trained in prestigious medical schools and research institutes, are consistently ranked nationally as Top Doctors by U.S. News & World Report.
Celebrating its 40th year in 2024, FCS has built a national reputation for excellence that is reflected in exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies and advanced treatments, including targeted therapies genomic-based treatment and immunotherapy. Our highest values are embodied by our outstanding team of highly trained and dedicated physicians, clinicians and staff.
Florida Cancer Specialists & Research Institute Appoints New Members to Senior Management
August 31st 2022Florida Cancer Specialists & Research Institute is pleased to welcome Jon Meyers, Nicole Radford, FACHE, MS, MT(ASCP), Bob Simon, Paul D. Summitt, and Samantha Watkins to its senior management team.
Ribociclib Dose Reductions Do Not Affect Survival Outcomes in HR+/HER2- Advanced Breast Cancer
June 7th 2022Overall survival outcomes for patients with hormone receptor–positive, HER2-negative advanced breast cancer who had dose modifications of ribociclib in the phase 3 MONALEESA-2 trial were comparable to those seen among patients who received the standard dose.
Emerging Chemotherapy-Free Approaches Raise Sequencing Questions in MCL Management
Martin F. Dietrich, MD, PhD, highlights recent updates in mantle cell lymphoma treatment, explains how new developments have raised sequencing questions, and projects where future research efforts will focus.
Advancing Cancer Care Through Clinical Trials in a Community Oncology Setting
May 10th 2022The American Cancer Society reported earlier this year that the risk of dying from cancer in the United States has decreased by 32% over the past 28 years, which translates to almost 3.5 million fewer cancer deaths.
Florida Cancer Specialists & Research Institute Launches FCS Hematology Oncology Review
April 4th 2022Florida Cancer Specialists & Research Institute launched a new website to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.